China Sanjiang Fine Chemicals Company Limited (CHINA SANJIANG) disclosed a further share buyback under its 2025 general mandate. Key points are as follows:
• Latest transaction: On 13 May 2026, the company repurchased 502,000 ordinary shares on the Hong Kong Stock Exchange at prices ranging between HK$5.08 and HK$5.17, with a volume-weighted average cost of HK$5.10 per share. The total consideration amounted to HK$2.56 million.
• Outstanding buybacks awaiting cancellation: Including the latest purchase, 3.50 million shares are pending cancellation. These shares were acquired in four tranches—1.00 million shares on 11 Sep 2025 at HK$1.75, 1.00 million on 26 Sep 2025 at HK$2.55, 1.00 million on 21 Oct 2025 at HK$2.52, and 0.50 million on 13 May 2026 at HK$5.10.
• Capital structure: The company’s issued share capital remains unchanged at 1.19 billion shares, as the repurchased shares have not yet been cancelled.
• Repurchase mandate utilisation: Since receiving shareholder approval on 30 May 2025 to buy back up to 119.00 million shares, CHINA SANJIANG has repurchased 3.50 million shares, representing 0.28% of the shares outstanding on the mandate date.
• Moratorium: In line with Hong Kong Listing Rules, the company is restricted from issuing new shares or transferring treasury shares until 12 August 2026.
The board confirmed that all repurchases were executed in compliance with Hong Kong Stock Exchange regulations and relevant legal requirements.
Comments